[A case of complete remission obtained with etoposide in uterine choriocarcinoma]. 1991

J Kikuchi, and T Sasaki, and K Ishibashi, and R Takaya, and H Mori, and H Endo, and I Shima, and T Moritsuka, and K Takahashi
Dept. of Obstetrics and Gynecology, Sendai National Hospital.

A 27-year-old female was admitted to Sendai National Hospital complaining of continuous slight genital bleeding for about one and a half year after incomplete abortion. At first visit, urinary hCG was elevated to 32,000 IU/l and ultrasonography revealed a heterogeneous tumor in the uterus body. After abdominal simple total hysterectomy, the sample was diagnosed pathologically as a uterine choriocarcinoma. The patient was treated with 2 courses of MTX, but this regimen was not so effective. Because of persistent elevation of urinary hCG, 2 courses of etoposide were performed and hCG was rapidly reduced to within LH level. Etoposide (25 mg/day per os) was given to the patient for about three months since hospitalization and now complete remission has been obtained.

UI MeSH Term Description Entries
D007044 Hysterectomy Excision of the uterus. Hysterectomies
D012074 Remission Induction Therapeutic act or process that initiates a response to a complete or partial remission level. Induction of Remission,Induction, Remission,Inductions, Remission,Remission Inductions
D002822 Choriocarcinoma A malignant metastatic form of trophoblastic tumors. Unlike the HYDATIDIFORM MOLE, choriocarcinoma contains no CHORIONIC VILLI but rather sheets of undifferentiated cytotrophoblasts and syncytiotrophoblasts (TROPHOBLASTS). It is characterized by the large amounts of CHORIONIC GONADOTROPIN produced. Tissue origins can be determined by DNA analyses: placental (fetal) origin or non-placental origin (CHORIOCARCINOMA, NON-GESTATIONAL). Choriocarcinomas
D003131 Combined Modality Therapy The treatment of a disease or condition by several different means simultaneously or sequentially. Chemoimmunotherapy, RADIOIMMUNOTHERAPY, chemoradiotherapy, cryochemotherapy, and SALVAGE THERAPY are seen most frequently, but their combinations with each other and surgery are also used. Multimodal Treatment,Therapy, Combined Modality,Combined Modality Therapies,Modality Therapies, Combined,Modality Therapy, Combined,Multimodal Treatments,Therapies, Combined Modality,Treatment, Multimodal,Treatments, Multimodal
D005047 Etoposide A semisynthetic derivative of PODOPHYLLOTOXIN that exhibits antitumor activity. Etoposide inhibits DNA synthesis by forming a complex with topoisomerase II and DNA. This complex induces breaks in double stranded DNA and prevents repair by topoisomerase II binding. Accumulated breaks in DNA prevent entry into the mitotic phase of cell division, and lead to cell death. Etoposide acts primarily in the G2 and S phases of the cell cycle. Demethyl Epipodophyllotoxin Ethylidine Glucoside,Celltop,Eposide,Eposin,Eto-GRY,Etomedac,Etopos,Etoposide Pierre Fabre,Etoposide Teva,Etoposide, (5S)-Isomer,Etoposide, (5a alpha)-Isomer,Etoposide, (5a alpha,9 alpha)-Isomer,Etoposide, alpha-D-Glucopyranosyl Isomer,Etoposido Ferrer Farma,Exitop,Lastet,NSC-141540,Onkoposid,Riboposid,Toposar,VP 16-213,VP-16,Vepesid,Vépéside-Sandoz,Eto GRY,Etoposide, alpha D Glucopyranosyl Isomer,NSC 141540,NSC141540,Teva, Etoposide,VP 16,VP 16 213,VP 16213,VP16,Vépéside Sandoz,alpha-D-Glucopyranosyl Isomer Etoposide
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000284 Administration, Oral The giving of drugs, chemicals, or other substances by mouth. Drug Administration, Oral,Administration, Oral Drug,Oral Administration,Oral Drug Administration,Administrations, Oral,Administrations, Oral Drug,Drug Administrations, Oral,Oral Administrations,Oral Drug Administrations
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D014594 Uterine Neoplasms Tumors or cancer of the UTERUS. Cancer of Uterus,Uterine Cancer,Cancer of the Uterus,Neoplasms, Uterine,Neoplasms, Uterus,Uterus Cancer,Uterus Neoplasms,Cancer, Uterine,Cancer, Uterus,Cancers, Uterine,Cancers, Uterus,Neoplasm, Uterine,Neoplasm, Uterus,Uterine Cancers,Uterine Neoplasm,Uterus Cancers,Uterus Neoplasm

Related Publications

J Kikuchi, and T Sasaki, and K Ishibashi, and R Takaya, and H Mori, and H Endo, and I Shima, and T Moritsuka, and K Takahashi
February 1990, Gan to kagaku ryoho. Cancer & chemotherapy,
J Kikuchi, and T Sasaki, and K Ishibashi, and R Takaya, and H Mori, and H Endo, and I Shima, and T Moritsuka, and K Takahashi
October 2017, Journal of global oncology,
J Kikuchi, and T Sasaki, and K Ishibashi, and R Takaya, and H Mori, and H Endo, and I Shima, and T Moritsuka, and K Takahashi
March 1986, Gan to kagaku ryoho. Cancer & chemotherapy,
J Kikuchi, and T Sasaki, and K Ishibashi, and R Takaya, and H Mori, and H Endo, and I Shima, and T Moritsuka, and K Takahashi
September 2023, Taiwanese journal of obstetrics & gynecology,
J Kikuchi, and T Sasaki, and K Ishibashi, and R Takaya, and H Mori, and H Endo, and I Shima, and T Moritsuka, and K Takahashi
April 1978, [Rinsho ketsueki] The Japanese journal of clinical hematology,
J Kikuchi, and T Sasaki, and K Ishibashi, and R Takaya, and H Mori, and H Endo, and I Shima, and T Moritsuka, and K Takahashi
September 1990, Gan to kagaku ryoho. Cancer & chemotherapy,
J Kikuchi, and T Sasaki, and K Ishibashi, and R Takaya, and H Mori, and H Endo, and I Shima, and T Moritsuka, and K Takahashi
May 1995, Gynecologic oncology,
J Kikuchi, and T Sasaki, and K Ishibashi, and R Takaya, and H Mori, and H Endo, and I Shima, and T Moritsuka, and K Takahashi
June 2004, Chinese medical sciences journal = Chung-kuo i hsueh k'o hsueh tsa chih,
J Kikuchi, and T Sasaki, and K Ishibashi, and R Takaya, and H Mori, and H Endo, and I Shima, and T Moritsuka, and K Takahashi
April 2004, La Revue de medecine interne,
J Kikuchi, and T Sasaki, and K Ishibashi, and R Takaya, and H Mori, and H Endo, and I Shima, and T Moritsuka, and K Takahashi
June 2013, Giornale italiano di dermatologia e venereologia : organo ufficiale, Societa italiana di dermatologia e sifilografia,
Copied contents to your clipboard!